He was scheduled to see his oncologist for taxol infusion today, but this happened again so he was instructed to present to an OSH, where he was noted to have melena and a HCT of 24.
Repeat CXR showed improvement.
He had a negative CTA at OSH and no effusion by ECHo at OSH.
In our ED, he was noted to have a HCT of 24 despite the unit he received at the OSH.
An 18G and 2 20G IVs were placed.
Past Medical History: HTN COPD - used albuterol inhaler Metastatic Melenoma: symptoms [**12-29**] melena DX:[**2-4**] after UGI Bleed when endoscopy showed gastric mass, 2 moles on back bx and confirmed as melenoma.
STAGING: CT Torso - multiple bilateral pulmonary nodules with a dominant mass in the LLL.
LLL mass biopsy c/w melanoma.
PET-CT on [**2101-2-21**] was notable for FDG-avid adenopathy in the mediastinum and left suprahilar region, multiple bilateral lung nodules, multiple liver lesions, a lymph node adjacent to the pancreatic head, and an "extremely" avid lesion in the greater curvature of the mid-body of the stomach.
An MRI of the brain was negative.
TREATMENT: HD IL-2 here at [**Hospital1 18**] from [**Date range (1) 86250**] (received 8 of 14 doses) and [**Date range (1) 86251**]/10 (received 9 of 14 doses).
Family History: Mother - lung cancer, death 30s, she was a smoker  Physical Exam: Admission Physical Exam: VS  HR 112  RR 13 BP 117/69  99% 4L Gen: well appearing, NAD, laying flat in bed HEENT: NCAT, MMM.
Sensation to light touch intact throughout.
Floor Physical Exam: VS T97.6 BP 118/68 HR 108 RR 22 100%RA Gen: Well appearing, no apparent distress, lying comfortably in bed with family at bedside HEENT: NCAT, EOMI, moist mucus membranes.
Strength and sensation grossly intact - ?weakness  Pertinent Results: [**2101-6-7**] 08:00PM   HCT-23.2*  [**2101-6-7**] 03:39PM   HGB-8.4* calcHCT-25 [**2101-6-7**] 03:37PM   GLUCOSE-96 UREA N-17 CREAT-0.4* SODIUM-136 POTASSIUM-4.9 CHLORIDE-98 TOTAL CO2-23 ANION GAP-20 [**2101-6-7**] 03:37PM   WBC-5.4 RBC-2.89* HGB-7.5* HCT-24.0* MCV-83 MCH-25.9* MCHC-31.2 RDW-19.9* [**2101-6-7**] 03:37PM   NEUTS-75.4* LYMPHS-20.1 MONOS-3.7 EOS-0.4 BASOS-0.4 [**2101-6-7**] 03:37PM   HYPOCHROM-3+ ANISOCYT-2+ POIKILOCY-2+ MACROCYT-OCCASIONAL MICROCYT-2+ POLYCHROM-OCCASIONAL SPHEROCYT-OCCASIONAL OVALOCYT-1+ SCHISTOCY-OCCASIONAL BURR-OCCASIONAL [**2101-6-7**] 03:37PM   PLT COUNT-601*# [**2101-6-7**] 03:37PM   PT-13.9* PTT-29.3 INR(PT)-1.2* .
CXR [**2101-6-7**]: IMPRESSION: Interval nearly resolution of previously noted left-sided pleural effusion with improved aeration of the left lung base.
ECHO [**2101-6-8**]: The left atrium is mildly dilated.
The pulmonary artery systolic pressure could not be determined.
There are no echocardiographic signs of tamponade.
Echo obtained [**6-8**] did not reveal any additional valvular or dynamic abnormalities to explain his dyspnea.
Continued to complain of dyspnea with exertion, but had appropriate saturation on room air (94-95%).
- Continue to have patient work with physical therapy - Nasal cannula/supplemental oxygen as needed - Blood transfusions at least weekly (Hct goal >25)  #.
His Hct also remained stable and his nausea was controlled.
He was ruled out for PE on OSH CTA and had no effusion on OSH Echo prior to last admission.
ECHO without structural explanation.
His current medical care goals are comfort but will continue to receive palliative Taxol and blood transfusions (for dyspnea control).
He was given an 8 day course of levofloxacin for concern for postobstructive pneumonia, of which he completed.
# Urinary obstruction: Noted to have difficulty with urination [**6-8**] with complete inablity on [**6-9**].
Release 24 hr Sig: One (1) Capsule, Sust.
